Symrise AG
Symrise sells flavours and fragrances for food, cosmetics and perfume, and also nutrition ingredients. Givaudan and dsm-firmenich do the same trade. It is not a closed oligopoly.
The formula goes into the customer's product. Changing it is a project: it can go badly and it can go well. This report does not say the ingredient is 1% of the cost or that the price is inelastic. Volume follows what the brand sells. A year in which the customer destocks is not normal earnings.
The dividend comes from that cash. It has to fit. It is not a toll on the perfume.
"The advantage is the formula the brand already has in the product and the team that already develops it with them. The brand can reformulate or add a second supplier. The moat narrows if the customer's volume falls, or if the formula is changed."
Loading the Vaultflake…
—
Health is debt against an ingredients business, not against the consumer brand. Quality is the formula margin after raw materials. Growth follows the customer's volume and new products. P/E is read against a year of strong customer sales, not against that year as normal. Shareholder return is the dividend, checked against cash. Do not call it a closed pricing power.
The P/E of a year in which brands restock is not normal earnings. EV/EBITDA is read without treating the formula as an asset that cannot be replaced. Do not use Givaudan's multiple as if the customer book were the same. A dash if SY1.DE is missing.
Not advice on Symrise. Vaultflake does not split flavours, fragrances and nutrition and does not treat the formula as captive. This is not a 1% cost. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the formula the brand already has in the product and the team that already develops it with them. The brand can reformulate or add a second supplier. The moat narrows if the customer's volume falls, or if the formula is changed.
Health is debt against an ingredients business, not against the consumer brand. Quality is the formula margin after raw materials. Growth follows the customer's volume and new products. P/E is read against a year of strong customer sales, not against that year as normal. Shareholder return is the dividend, checked against cash. Do not call it a closed pricing power.
The P/E of a year in which brands restock is not normal earnings. EV/EBITDA is read without treating the formula as an asset that cannot be replaced. Do not use Givaudan's multiple as if the customer book were the same. A dash if SY1.DE is missing.
Not advice on Symrise. Vaultflake does not split flavours, fragrances and nutrition and does not treat the formula as captive. This is not a 1% cost. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Materials · Industrial Gases
Materials · Industrial Gases
Materials · Chemicals
Materials · Mining
Materials · Stainless Steel
Materials · Architectural Paint
A free account opens the interactive chart. The Vault assistant is Premium.